Impact of Two Doses of Agonist Trigger on Assisted Reproductive Technology Outcome

Abstract

women in the age-group of 21–42 years, identified as hyperresponders by ovarian reserve markers, anti-Mullerian Hormone [AMH ≥3.5 ng/mL and or antral follicle count (AFC) of ≥20, >14 intermediary follicles and/or a high serum estradiol (E2) level (>3500 pg/mL] on the day of trigger, receiving two doses of agonist trigger 12-hour apart were included. Women with hypothalamic amenorrhea and hypogonadotropic-hypogonadism were excluded. So 86 women fulfilling the selection criteria were analyzed. Ovarian reserve assessment (determined by AMH levels, AFC on day 2 or 3 of menstrual cycle) was done after detailed history and clinical examination. In t r o d u c t I o n